Literature DB >> 26559592

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.

Timothy A Chan1, Jedd D Wolchok, Alexandra Snyder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26559592     DOI： 10.1056/NEJMc1508163

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  72 in total

Review 1.  Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.

Authors:  Jessica M Moskovitz; Jennifer Moy; Tanguy Y Seiwert; Robert L Ferris
Journal:  Oncologist       Date:  2017-05-15

2.  EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer.

Authors:  Zhong-Yi Dong; Jia-Tao Zhang; Si-Yang Liu; Jian Su; Chao Zhang; Zhi Xie; Qing Zhou; Hai-Yan Tu; Chong-Rui Xu; Li-Xu Yan; Yu-Fa Li; Wen-Zhao Zhong; Yi-Long Wu
Journal:  Oncoimmunology       Date:  2017-07-26       Impact factor: 8.110

Review 3.  Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.

Authors:  Xianda Zhao; Audre May; Emil Lou; Subbaya Subramanian
Journal:  Transl Res       Date:  2018-02-12       Impact factor: 7.012

Review 4.  Unravelling biology and shifting paradigms in cancer with single-cell sequencing.

Authors:  Timour Baslan; James Hicks
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

5.  New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story?

Authors:  Markus Eckstein; Shilpa Gupta
Journal:  Ann Transl Med       Date:  2019-07

Review 6.  Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.

Authors:  Sabrina Rossi; Luca Toschi; Angelo Castello; Fabio Grizzi; Luigi Mansi; Egesta Lopci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-16       Impact factor: 9.236

7.  Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.

Authors:  Teresa Davoli; Hajime Uno; Eric C Wooten; Stephen J Elledge
Journal:  Science       Date:  2017-01-20       Impact factor: 47.728

8.  Identification of essential genes for cancer immunotherapy.

Authors:  Shashank J Patel; Neville E Sanjana; Rigel J Kishton; Arash Eidizadeh; Suman K Vodnala; Maggie Cam; Jared J Gartner; Li Jia; Seth M Steinberg; Tori N Yamamoto; Anand S Merchant; Gautam U Mehta; Anna Chichura; Ophir Shalem; Eric Tran; Robert Eil; Madhusudhanan Sukumar; Eva Perez Guijarro; Chi-Ping Day; Paul Robbins; Steve Feldman; Glenn Merlino; Feng Zhang; Nicholas P Restifo
Journal:  Nature       Date:  2017-08-07       Impact factor: 49.962

Review 9.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16

Review 10.  Functional genomics: paving the way for more successful cancer immunotherapy.

Authors:  Reham Ajina; Danielle Zamalin; Louis M Weiner
Journal:  Brief Funct Genomics       Date:  2019-03-22       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.